What we do
- Educational Resources
- Educational clips
- Webinars
- Q&As
- AL amyloidosis vs myeloma
- Living with AL amyloidosis
- Diagnosis, treatment and monitoring of AL amyloidosis
- CAR T-cell therapy side effects
- Minimal Residual Disease (MRD)
- Chimeric Antigen Receptor T cell (CAR-T) therapy
- SARS-CoV-2 (COVID-19) Vaccination and Treatment
- European Union (EU) Funded Projects
- Health Technology Assessment (HTA)
- H2020 MMPredict
- Toolkits
- Factsheets
- Conference reports
- Patient guides